Published in Carbohydr Res on June 11, 1997
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin Diagn Lab Immunol (1998) 2.10
Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule. Eukaryot Cell (2006) 1.21
Cas3p belongs to a seven-member family of capsule structure designer proteins. Eukaryot Cell (2004) 1.19
Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides. J Biol Chem (2008) 1.14
Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans. Eukaryot Cell (2007) 0.87
Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy. Infect Immun (1998) 0.80
Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly. Eukaryot Cell (2014) 0.79
Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure. Front Cell Infect Microbiol (2016) 0.75
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol Immunol (1980) 2.98
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun (1998) 2.12
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun (1988) 2.11
Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res (1990) 2.08
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res (1984) 1.79
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydr Res (1998) 1.72
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect Immun (1980) 1.65
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure. Infect Immun (1999) 1.60
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn Immunol (1984) 1.57
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun (1989) 1.55
Localization of mannoprotein in Cryptococcus neoformans. J Bacteriol (1989) 1.52
Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect Immun (1997) 1.52
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein. J Immunol (1997) 1.43
Galactoxylomannans of Cryptococcus neoformans. Infect Immun (1992) 1.42
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res (1992) 1.34
Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans. J Med Vet Mycol (1990) 1.32
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr Top Med Mycol (1985) 1.30
Soluble polysaccharides of Cryptococcus neoformans. Curr Top Med Mycol (1988) 1.29
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun (1997) 1.28
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun (1997) 1.27
Capsular polysaccharides of Clostridium perfringens Hobbs 5. Biochemistry (1971) 1.20
Composition of the capsular polysaccharides of Clostridium perfringens as a basis for their classification by chemotypes. Can J Microbiol (1975) 1.16
The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen. Infect Immun (1992) 1.11
Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun (2001) 1.08
Immunochemistry of the capsular polysaccharides from Clostridium perfringens: selected Hobbs strains 1, 5, 9, and 10. Infect Immun (1972) 1.07
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr Res (1996) 1.07
Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. Infect Immun (2000) 1.06
Serotyping of Cryptococcus neoformans by dot enzyme assay. J Clin Microbiol (1996) 1.04
Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohydr Res (1991) 1.00
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication. Clin Exp Immunol (1997) 1.00
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect Immun (1995) 0.99
Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 gene. Infect Immun (1997) 0.97
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol (1990) 0.97
T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A. Infect Immun (1993) 0.95
Ultrastructure of acapsular mutant Cryptococcus neoformans cap 67 and monosaccharide composition of cell extracts. Mycopathologia (1986) 0.94
Specificity of Cryptococcus neoformans factor sera determined by enzyme-linked immunosorbent assay and dot enzyme assay. Infect Immun (1993) 0.92
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J Immunol (2001) 0.92
Immunochemical evidence for multiple serotypes of Bacteroides fragilis. J Clin Microbiol (1979) 0.92
Pathogenesis of Cryptococcus neoformans is associated with quantitative differences in multiple virulence factors. Mycopathologia (1999) 0.90
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy. Carbohydr Res (1995) 0.88
Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy. Carbohydr Res (1997) 0.88
Capsular polysaccharide of Clostridium perfringens Hobbs 10. Infect Immun (1974) 0.88
Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure. FEMS Immunol Med Microbiol (1999) 0.87
Immunoelectronmicroscopic characterization of monoclonal antibodies (MAbs) against Cryptococcus neoformans. Mol Cell Probes (1989) 0.86
Capsular polysaccharide of Clostridium perfringens Hobbs 9. Infect Immun (1977) 0.86
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis. J Neuroimmunol (2000) 0.86
Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype B. Carbohydr Res (1991) 0.85
Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 5 as determined by NMR spectroscopy. Carbohydr Res (1997) 0.84
Metabolism in vitro and in vivo of pentazocine. Biochem Pharmacol (1969) 0.83
In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies. Infect Immun (1999) 0.82
Ventriculoperitoneal shunt malfunction due to migration of the abdominal catheter into the scrotum. J Pediatr Surg (1987) 0.80
Biochemical and serological characteristics of soluble yeast phase antigens of Histoplasma capsulatum. Mycopathologia (1979) 0.78
Identification of iduronic acid as a constituent of the "type-specific" polysaccharide of Clostridium perfringens Hobbs 10. Carbohydr Res (1974) 0.77
Common polysaccharide antigens from the cell envelope of Clostridium perfringens type A. Infect Immun (1981) 0.75
A 1H NMR spectroscopic approach to the unambiguous determination of glycosyl linkage positions in oligosaccharides. Anal Biochem (1998) 0.75
Analysis of the common polysaccharide antigens from the cell envelope of Clostridium perfringens type A. Carbohydr Res (1983) 0.75
Polysaccharides from Peptostreptococcus anaerobius and structure of the species-specific antigen. Carbohydr Res (1990) 0.75
4-Methylmorpholine N-oxide-methyl sulfoxide soluble glucan of Piptoporus betulinus. Carbohydr Res (1990) 0.75